Side-by-side comparison of mechanisms, dosing, interactions, and stacking potential.
| Alpha Lipoic Acid (ALA) | Thiamine (Benfotiamine) | |
|---|---|---|
| Category | Supplements | Vitamins |
| Standard Dose | 300-600mg R-ALA daily | 150-300mg benfotiamine daily |
| Timing | On empty stomach, 30-60 min before meals. Split doses for higher amounts. | With meals. Divide higher doses. |
| Cycle Duration | ongoing or cycle 12 weeks on, 4 weeks off | ongoing |
| Evidence Level | strong_human | strong_human |
ALA is a dithiol compound that functions as a cofactor for mitochondrial alpha-keto acid dehydrogenases (pyruvate dehydrogenase, alpha-ketoglutarate dehydrogenase). Both ALA and its reduced form DHLA are potent antioxidants capable of regenerating other antioxidants including vitamin C, vitamin E, and glutathione. ALA activates AMPK, improving glucose uptake via GLUT4 translocation, and modulates NF-kB-mediated inflammatory signaling. It chelates redox-active metals (Fe2+, Cu2+).
300-600mg R-ALA daily
On empty stomach, 30-60 min before meals. Split doses for higher amounts.
ongoing or cycle 12 weeks on, 4 weeks off
Benfotiamine is a lipophilic S-acyl derivative of thiamine with 5x greater bioavailability than water-soluble thiamine. Once absorbed, it is converted to thiamine pyrophosphate (TPP), the active coenzyme for pyruvate dehydrogenase (linking glycolysis to Krebs cycle), alpha-ketoglutarate dehydrogenase (Krebs cycle), branched-chain alpha-ketoacid dehydrogenase (BCAA metabolism), and transketolase (pentose phosphate pathway). Benfotiamine specifically activates transketolase, shunting glucose metabolites away from damaging AGE (advanced glycation end-product) formation pathways, hexosamine pathway, and PKC activation — the three major pathways of hyperglycemic damage.
150-300mg benfotiamine daily
With meals. Divide higher doses.
ongoing
Take our free assessment to get personalized recommendations based on your health goals, current stack, and biomarkers.
Get Your Free Protocol →or take the assessment →